Immune Markers and Tumor-Related Processes Predict Neoadjuvant Therapy Response in the WSG-ADAPT HER2-Positive/Hormone Receptor-Positive Trial in Early Breast Cancer

Harbeck, Nadia; von Schumann, Raquel; Kates, Ronald Ernest; Braun, Michael; Kuemmel, Sherko; Schumacher, Claudia; Potenberg, Jochem; Malter, Wolfram; Augustin, Doris; Aktas, Bahriye; Forstbauer, Helmut; Tio, Joke; Grischke, Eva-Maria; Biehl, Claudia; Liedtke, Cornelia; De Haas, Sanne Lysbet; Deurloo, Regula; Wuerstlein, Rachel; Kreipe, Hans Heinrich; Gluz, Oleg

Immune Markers and Tumor-Related Processes Predict Neoadjuvant Therapy Response in the WSG-ADAPT HER2-Positive/Hormone Receptor-Positive Trial in Early Breast Cancer

Autor(en):

Harbeck, Nadia; von Schumann, Raquel; Kates, Ronald Ernest; Braun, Michael; Kuemmel, Sherko; Schumacher, Claudia; Potenberg, Jochem; Malter, Wolfram; Augustin, Doris; Aktas, Bahriye; Forstbauer, Helmut; Tio, Joke; Grischke, Eva-Maria; Biehl, Claudia; Liedtke, Cornelia; De Haas, Sanne Lysbet; Deurloo, Regula; Wuerstlein, Rachel; Kreipe, Hans Heinrich; Gluz, Oleg

Tübinger Autor(en):

Grischke, Eva-Maria

Erschienen in:

Cancers (2021), Bd. 13 (19), Article 4884

Verlagsangabe:

Mdpi

Sprache:

Englisch

Referenz zum Volltext:

http://dx.doi.org/10.3390/cancers13194884

ISSN:

2072-6694